Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1155413

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1155413

Europe Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 105 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Sustained Release Excipients Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

Methacrylate polymers, which also offer gastro-resistant functionality, are frequently utilized in delayed-release dosage forms. Although the usage of two-polymer matrix systems is expanding, hydroxypropyl methylcellulose (HPMC) remains the excipient of choice in monolithic delivery systems. Matrix systems and functional coatings are the two main formulation techniques that can be used to create sustained release kinetics.

In order to produce a membrane surrounding the tablet that regulates the pace of API release in relation to the rate of coating layer evaporation through which the medicine will diffuse and dissolve, functional coatings are used. These reservoir systems are another name for such sustained release systems. This strategy can be flexible because the pores, coating type, and thickness can all be changed to alter the controlled release profile. The API is uniformly disseminated within a matrix made of polymers in formulations for sustained release based on a matrix.

Matrix systems are divided into hydrophobic and hydrophilic matrix systems based on the rate-controlling polymeric characteristics, which exhibit various release mechanisms. The API is released by diffusion through the thick gel layer and also by matrix erosion in the hydrophilic type of matrix systems. In this, the polymer hydrates and expands upon contact with the gastrointestinal medium, generating a gel layer on the system's surface. Different polymer kinds, grades, and quantities can be used to modify released kinetics, but they also depend on the solubility of the API.

Due to the aging populations, non-communicable diseases, multimorbidity, and frailty in Europe, the emergence of diseases like COVID-19 are especially pertinent. A study conducted throughout the region reported that the nations with the largest percentages of senior citizens were Finland, Italy, Greece, Portugal, and Germany. The report indicated that in these countries older people were living with disabilities on average. But the greatest rates were found in Bulgaria, Croatia, and Hungary. Additionally, the region's burden of cardiovascular diseases (CVD) goes beyond mortality. A high prevalence of the disease/disorder is observed in Eastern Europe than in the western part.

The Germany market dominated the Europe Sustained Release Excipients Market by Country in 2021; thereby, achieving a market value of $153.4 million by 2028. The UK market would showcase a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is anticipated to grow at a CAGR of 8.9% during (2022 - 2028).

Based on Route of Administration, the market is segmented into Oral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, Intramuscular, and Others. Based on Product, the market is segmented into Polymers, Minerals, Sugars, Gelatin & Chitosan, and Others. Based on Technology, the market is segmented into Targeted Delivery, Implants, Wurster Technique, Transdermal, Micro Encapsulation, and Coacervation & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefosse, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

  • Oral
  • Transdermal
  • Vaginal
  • Intravenous
  • Ophthalmic
  • Subcutaneous
  • Intramuscular
  • Others

By Product

  • Polymers
  • Minerals
  • Sugars
  • Gelatin & Chitosan
  • Others

By Technology

  • Targeted Delivery
  • Implants
  • Wurster Technique
  • Transdermal
  • Micro Encapsulation
  • Coacervation & Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • BASF SE
  • International Flavors & Fragrances, Inc.
  • Ashland Global Holdings Inc.
  • Evonik Industries AG
  • Croda International Plc
  • Gattefosse
  • Merck Group
  • Pfizer, Inc.
  • Novartis AG
  • AstraZeneca Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Sustained Release Excipients Market, by Route of Administration
    • 1.4.2 Europe Sustained Release Excipients Market, by Product
    • 1.4.3 Europe Sustained Release Excipients Market, by Technology
    • 1.4.4 Europe Sustained Release Excipients Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Sustained Release Excipients Market

Chapter 4. Europe Sustained Release Excipients Market by Route of Administration

  • 4.1 Europe Oral Market by Country
  • 4.2 Europe Transdermal Market by Country
  • 4.3 Europe Vaginal Market by Country
  • 4.4 Europe Intravenous Market by Country
  • 4.5 Europe Ophthalmic Market by Country
  • 4.6 Europe Subcutaneous Market by Country
  • 4.7 Europe Intramuscular Market by Country
  • 4.8 Europe Others Market by Country

Chapter 5. Europe Sustained Release Excipients Market by Product

  • 5.1 Europe Polymers Market by Country
  • 5.2 Europe Minerals Market by Country
  • 5.3 Europe Sugars Market by Country
  • 5.4 Europe Gelatin & Chitosan Market by Country
  • 5.5 Europe Others Market by Country

Chapter 6. Europe Sustained Release Excipients Market by Technology

  • 6.1 Europe Targeted Delivery Market by Country
  • 6.2 Europe Implants Market by Country
  • 6.3 Europe Wurster Technique Market by Country
  • 6.4 Europe Transdermal Market by Country
  • 6.5 Europe Micro Encapsulation Market by Country
  • 6.6 Europe Coacervation & Others Market by Country

Chapter 7. Europe Sustained Release Excipients Market by Country

  • 7.1 Germany Sustained Release Excipients Market
    • 7.1.1 Germany Sustained Release Excipients Market by Route of Administration
    • 7.1.2 Germany Sustained Release Excipients Market by Product
    • 7.1.3 Germany Sustained Release Excipients Market by Technology
  • 7.2 UK Sustained Release Excipients Market
    • 7.2.1 UK Sustained Release Excipients Market by Route of Administration
    • 7.2.2 UK Sustained Release Excipients Market by Product
    • 7.2.3 UK Sustained Release Excipients Market by Technology
  • 7.3 France Sustained Release Excipients Market
    • 7.3.1 France Sustained Release Excipients Market by Route of Administration
    • 7.3.2 France Sustained Release Excipients Market by Product
    • 7.3.3 France Sustained Release Excipients Market by Technology
  • 7.4 Russia Sustained Release Excipients Market
    • 7.4.1 Russia Sustained Release Excipients Market by Route of Administration
    • 7.4.2 Russia Sustained Release Excipients Market by Product
    • 7.4.3 Russia Sustained Release Excipients Market by Technology
  • 7.5 Spain Sustained Release Excipients Market
    • 7.5.1 Spain Sustained Release Excipients Market by Route of Administration
    • 7.5.2 Spain Sustained Release Excipients Market by Product
    • 7.5.3 Spain Sustained Release Excipients Market by Technology
  • 7.6 Italy Sustained Release Excipients Market
    • 7.6.1 Italy Sustained Release Excipients Market by Route of Administration
    • 7.6.2 Italy Sustained Release Excipients Market by Product
    • 7.6.3 Italy Sustained Release Excipients Market by Technology
  • 7.7 Rest of Europe Sustained Release Excipients Market
    • 7.7.1 Rest of Europe Sustained Release Excipients Market by Route of Administration
    • 7.7.2 Rest of Europe Sustained Release Excipients Market by Product
    • 7.7.3 Rest of Europe Sustained Release Excipients Market by Technology

Chapter 8. Company Profiles

  • 8.1 BASF SE
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
  • 8.2 International Flavors & Fragrances, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segment & Regional Analysis
    • 8.2.4 Research & Development Expense
  • 8.3 Ashland Global Holdings Inc. (Pharmachem Laboratories Inc.)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
  • 8.4 Evonik Industries AG (RAG-Stiftung)
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Product Launches and Product Expansions:
      • 8.4.5.3 Acquisition and Mergers:
  • 8.5 Croda International PLC
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
  • 8.6 Merck Group
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Pfizer, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional & Segmental Analysis
    • 8.7.4 Research & Development Expense
  • 8.8 Novartis AG
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
  • 8.9 AstraZeneca PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
  • 8.10. Gattefosse
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 4 Europe Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 5 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Transdermal Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Transdermal Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Vaginal Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Vaginal Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Intravenous Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Europe Intravenous Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Europe Ophthalmic Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Europe Ophthalmic Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Europe Subcutaneous Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Subcutaneous Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Intramuscular Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Europe Intramuscular Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Europe Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 22 Europe Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 23 Europe Polymers Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Europe Polymers Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Europe Minerals Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Europe Minerals Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Europe Sugars Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Europe Sugars Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Europe Gelatin & Chitosan Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Europe Gelatin & Chitosan Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Europe Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 34 Europe Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 35 Europe Targeted Delivery Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Europe Targeted Delivery Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Europe Implants Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Europe Implants Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Europe Wurster Technique Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Europe Wurster Technique Market by Country, 2022 - 2028, USD Million
  • TABLE 41 Europe Transdermal Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Europe Transdermal Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Europe Micro Encapsulation Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Europe Micro Encapsulation Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Europe Coacervation & Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Europe Coacervation & Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 Europe Sustained Release Excipients Market by Country, 2018 - 2021, USD Million
  • TABLE 48 Europe Sustained Release Excipients Market by Country, 2022 - 2028, USD Million
  • TABLE 49 Germany Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 50 Germany Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 51 Germany Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 52 Germany Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 53 Germany Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 54 Germany Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 55 Germany Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 56 Germany Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 57 UK Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 58 UK Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 59 UK Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 60 UK Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 61 UK Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 62 UK Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 63 UK Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 64 UK Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 65 France Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 66 France Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 67 France Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 68 France Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 69 France Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 70 France Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 71 France Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 72 France Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 73 Russia Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 74 Russia Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 75 Russia Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 76 Russia Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 77 Russia Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 78 Russia Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 79 Russia Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 80 Russia Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 81 Spain Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 82 Spain Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 83 Spain Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 84 Spain Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 85 Spain Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 86 Spain Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 87 Spain Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 88 Spain Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 89 Italy Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 90 Italy Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 91 Italy Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 92 Italy Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 93 Italy Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 94 Italy Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 95 Italy Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 96 Italy Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 97 Rest of Europe Sustained Release Excipients Market, 2018 - 2021, USD Million
  • TABLE 98 Rest of Europe Sustained Release Excipients Market, 2022 - 2028, USD Million
  • TABLE 99 Rest of Europe Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 100 Rest of Europe Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 101 Rest of Europe Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Rest of Europe Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
  • TABLE 103 Rest of Europe Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
  • TABLE 104 Rest of Europe Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
  • TABLE 105 Key Information - BASF SE
  • TABLE 106 Key information - International Flavors & Fragrances, Inc.
  • TABLE 107 Key Information - Ashland Global Holdings Inc.
  • TABLE 108 Key Information - Evonik Industries AG
  • TABLE 109 Key Information - Croda International PLC
  • TABLE 110 key Information - Merck GrouP
  • TABLE 111 Key Information - Pfizer, Inc.
  • TABLE 112 Key Information - Novartis AG
  • TABLE 113 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 114 Key Information - Gattefosse

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Evonik Industries AG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!